Acrivon Therapeutics, Inc.'s total assets for Q2 2025 were $158.58M, a decrease of -10.07% from the previous quarter. ACRV total liabilities were $15.55M for the fiscal quarter, a -2.59% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.